600812 华北制药
已收盘 10-09 15:00:00
资讯
新帖
简况
华北制药：股票交易异常波动 链霉素产品收入规模小
格隆汇 · 10-09 19:01
华北制药：股票交易异常波动 链霉素产品收入规模小
2连板华北制药：注射用硫酸链霉素销售收入规模较小
证券之星 · 10-09 19:01
2连板华北制药：注射用硫酸链霉素销售收入规模较小
华北制药（600812）10月8日主力资金净买入1.36亿元
证券之星 · 10-09 08:14
华北制药（600812）10月8日主力资金净买入1.36亿元
10月8日华北制药（600812）龙虎榜数据：北向资金净卖出491.34万元
证券之星 · 10-08 17:43
10月8日华北制药（600812）龙虎榜数据：北向资金净卖出491.34万元
异动快报：华北制药（600812）10月8日9点48分触及涨停板
证券之星 · 10-08 09:50
异动快报：华北制药（600812）10月8日9点48分触及涨停板
华北制药（600812）9月23日主力资金净卖出952.60万元
证券之星 · 09-24
华北制药（600812）9月23日主力资金净卖出952.60万元
异动快报：华北制药（600812）9月21日10点20分触及涨停板
证券之星 · 09-21
异动快报：华北制药（600812）9月21日10点20分触及涨停板
华北制药：截至2026年6月30日，公司股东总数为88,579户
证券之星 · 09-18
华北制药：截至2026年6月30日，公司股东总数为88,579户
华北制药：公司及下属单位原料药苄星青霉素及制剂药注射用苄星青霉素
证券之星 · 09-18
华北制药：公司及下属单位原料药苄星青霉素及制剂药注射用苄星青霉素
华北制药：青霉素类产品共计30多种
证券之星 · 09-18
华北制药：青霉素类产品共计30多种
华北制药：高精度、大通量、高协同的模块化微反应器创制及产业创新性应用
证券之星 · 09-07
华北制药：高精度、大通量、高协同的模块化微反应器创制及产业创新性应用
华北制药：持续深化改革推动高质量发展
证券之星 · 09-07
华北制药：持续深化改革推动高质量发展
华北制药：公司积极推进相关产品研发事宜
证券之星 · 09-07
华北制药：公司积极推进相关产品研发事宜
华北制药：2026年上半年有息负债规模较年初有所降低
证券之星 · 09-07
华北制药：2026年上半年有息负债规模较年初有所降低
每周股票复盘：华北制药（600812）为子公司担保1.8亿元
证券之星 · 09-06
每周股票复盘：华北制药（600812）为子公司担保1.8亿元
华北制药（600812）披露为下属子公司提供担保公告，9月2日股价下跌1.64%
证券之星 · 09-02
华北制药（600812）披露为下属子公司提供担保公告，9月2日股价下跌1.64%
股市必读：华北制药新发布《关于下属公司获得《药品补充申请批准通知书》的公告》
证券之星 · 08-31
股市必读：华北制药新发布《关于下属公司获得《药品补充申请批准通知书》的公告》
每周股票复盘：华北制药（600812）注射用赖氨匹林通过一致性评价
证券之星 · 08-30
每周股票复盘：华北制药（600812）注射用赖氨匹林通过一致性评价
华北制药最新公告：子公司注射用赖氨匹林通过一致性评价并新增规格
证券之星 · 08-27
华北制药最新公告：子公司注射用赖氨匹林通过一致性评价并新增规格
每周股票复盘：华北制药（600812）Q2净利降57.01%
证券之星 · 08-23
每周股票复盘：华北制药（600812）Q2净利降57.01%
暂无数据
公司概况
公司名称：
华北制药股份有限公司
所属行业：
医药制造业
上市日期：
1994-01-14
主营业务：
华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是化学药、生物药、维生素及健康消费品、农兽药。
发行价格：
4.00
{"stockData":{"symbol":"600812","market":"SH","secType":"STK","nameCN":"华北制药","latestPrice":6.03,"timestamp":1791529200000,"preClose":5.48,"halted":0,"volume":115872239,"delay":0,"changeRate":0.1004,"floatShares":1716000000,"shares":1716000000,"eps":0.072,"marketStatus":"已收盘","change":0.55,"latestTime":"10-09 15:00:00","open":5.6,"high":6.03,"low":5.58,"amount":688000000,"amplitude":0.0821,"askPrice":0,"askSize":0,"bidPrice":6.03,"bidSize":197671,"shortable":0,"etf":0,"ttmEps":0.072,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.48,"symbolType":"stock","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":6.03,"lowLimit":4.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1715730370,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":83.75,"roe":"1.15%","epsLYR":0.107,"committee":0,"marketValue":10346000000,"turnoverRate":0.0675,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-12。","floatMarketCap":10346000000},"requestUrl":"/m/hq/s/600812/tweets","defaultTab":"tweets","newsList":[{"id":"2674385633","title":"华北制药：股票交易异常波动 链霉素产品收入规模小","url":"https://stock-news.laohu8.com/highlight/detail?id=2674385633","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674385633?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:01","pubTimestamp":1791543672,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0191","600812","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856122","title":"2连板华北制药：注射用硫酸链霉素销售收入规模较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674856122?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:01","pubTimestamp":1791543667,"startTime":"0","endTime":"0","summary":"公司关注到近期市场对“鼠疫”相关热点概念关注度较高。经核实，公司注射用硫酸链霉素说明书显示其适应症包括可单用于治疗土拉菌病，或与其他抗菌药物联合用于鼠疫、腹股沟肉芽肿、布鲁菌病、鼠咬热等的治疗。该产品为公司传统抗生素品种，2025年及2026年1-6月该产品销售收入规模较小，不会对公司整体经营业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900031926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","600812","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886769","title":"华北制药（600812）10月8日主力资金净买入1.36亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674886769?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:14","pubTimestamp":1791504846,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，华北制药报收于5.48元，上涨10.04%，涨停，换手率5.27%，成交量90.34万手，成交额4.94亿元。近5日资金流向一览见下表：华北制药融资融券信息显示，融资方面，当日融资买入4590.91万元，融资偿还5145.77万元，融资净偿还554.86万元。华北制药主营业务：从事医药产品的研发、生产和销售等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900005849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","BK0028","600812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673843073","title":"10月8日华北制药（600812）龙虎榜数据：北向资金净卖出491.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673843073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673843073?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:43","pubTimestamp":1791452639,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年10月8日公布的交易公开信息显示，华北制药因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年10月8日收盘，华北制药报收于5.48元，上涨10.04%，涨停，换手率5.27%，成交量90.34万手，成交额4.94亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出491.34万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800023255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0191","600812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673830044","title":"异动快报：华北制药（600812）10月8日9点48分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2673830044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673830044?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:50","pubTimestamp":1791424238,"startTime":"0","endTime":"0","summary":"证券之星10月8日盘中消息，9点48分华北制药（600812）触及涨停板。其所属行业化学制药目前上涨。领涨股为华北制药。该股为维生素，流感，雄安新区概念热股，当日维生素概念上涨1.3%，流感概念上涨1.27%，雄安新区概念上涨0.91%。9月30日的资金流向数据方面，主力资金净流入1414.56万元，占总成交额7.93%，游资资金净流出1292.68万元，占总成交额7.25%，散户资金净流出121.88万元，占总成交额0.68%。近5日资金流向一览见下表：华北制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800005096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600812","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669376654","title":"华北制药（600812）9月23日主力资金净卖出952.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669376654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669376654?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:30","pubTimestamp":1790209859,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，华北制药报收于4.95元，下跌2.94%，换手率2.59%，成交量44.44万手，成交额2.23亿元。近5日资金流向一览见下表：华北制药融资融券信息显示，融资方面，当日融资买入2054.96万元，融资偿还1983.08万元，融资净买入71.88万元。华北制药主营业务：从事医药产品的研发、生产和销售等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","BK0239","600812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139421","title":"异动快报：华北制药（600812）9月21日10点20分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139421","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139421?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:25","pubTimestamp":1789957528,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，10点20分华北制药（600812）触及涨停板。其所属行业化学制药目前上涨。领涨股为亚虹医药科技。该股为医药，化学原料药，流感概念热股，当日医药概念上涨3.34%，化学原料药概念上涨3.27%，流感概念上涨3.12%。9月18日的资金流向数据方面，主力资金净流入1555.92万元，占总成交额11.15%，游资资金净流出624.09万元，占总成交额4.47%，散户资金净流出931.83万元，占总成交额6.68%。近5日资金流向一览见下表：华北制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100005975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600812","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668947846","title":"华北制药：截至2026年6月30日，公司股东总数为88,579户","url":"https://stock-news.laohu8.com/highlight/detail?id=2668947846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668947846?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:15","pubTimestamp":1789726511,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药(600812)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价为什么上蹿下跳，能否查询股东户数，是不是又把散户套住了华北制药回复：尊敬的投资者，您好。公司按要求在定期报告中披露截至报告期末的股东人数。截至2026年6月30日，公司股东总数为88,579户。具体内容请详见《2026年半年度报告》第六节股份变动及股东情况相关内容。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800028750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600812","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668194275","title":"华北制药：公司及下属单位原料药苄星青霉素及制剂药注射用苄星青霉素","url":"https://stock-news.laohu8.com/highlight/detail?id=2668194275","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668194275?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:06","pubTimestamp":1789725985,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药(600812)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有抗感染治疗梅毒的药品吗？华北制药回复：尊敬的投资者，您好。公司及下属单位原料药苄星青霉素及制剂药注射用苄星青霉素，主要用于预防风湿热复发，也可用于控制链球菌感染的流行。治疗用药还请谨遵医嘱。上述产品收入占公司总收入的比重较小。敬请投资者审慎决策，注意投资风险。具体情况请参见《2025年年度报告》及相关公告，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800028506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","BK0028","600812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668759942","title":"华北制药：青霉素类产品共计30多种","url":"https://stock-news.laohu8.com/highlight/detail?id=2668759942","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668759942?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:06","pubTimestamp":1789725969,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药(600812)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！贵公司青梅素是否提供海外？另外，2026年青梅素厂存多少谢谢华北制药回复：尊敬的投资者，您好。目前公司青霉素类产品共计30多种，其中原料药阿莫西林、普鲁卡因青霉素，以及制剂药阿莫西林胶囊等产品出口海外市场。公司2025年全年实现出口收入19.53亿元。具体情况请参见《2025年年度报告》及相关公告，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800028493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600812","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665147083","title":"华北制药：高精度、大通量、高协同的模块化微反应器创制及产业创新性应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2665147083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665147083?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:00","pubTimestamp":1788775228,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药09月07日在投资者关系平台上答复投资者关心的问题。后续公司将继续围绕“五大板块”协同发展，以“提质增效”为中心，深化营销改革，坚持创新驱动，扩大出口规模，持续降本增效，加快重点项目建设，探索多形式对外合作，稳步提升盈利水平。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700024078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","600812","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314895","title":"华北制药：持续深化改革推动高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314895?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:48","pubTimestamp":1788774495,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药09月07日在投资者关系平台上答复投资者关心的问题。二级市场股价易受多重市场外部因素影响。公司将继续围绕“五大板块”协同发展，持续深化改革，推动营销变革，突出科技引领，夯实管理根基，奋力推动公司高质量发展。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600812","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314813","title":"华北制药：公司积极推进相关产品研发事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314813?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:48","pubTimestamp":1788774494,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药(600812)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：阿尔兹海默症的药品开发进度能不能说明下？华北制药回复：尊敬的投资者，您好。公司积极推进相关产品研发事宜。由于药品的前期研发以及产品从研制、临床试验报批到投产的周期长、环节多，容易受到技术、审批、政策等诸多因素影响，敬请投资者注意投资风险。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600812","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314844","title":"华北制药：2026年上半年有息负债规模较年初有所降低","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314844?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:48","pubTimestamp":1788774488,"startTime":"0","endTime":"0","summary":"证券之星消息，华北制药09月07日在投资者关系平台上答复投资者关心的问题。有计划通过增发补充流动资金吗华北制药回复：尊敬的投资者，您好。公司拓展融资渠道，优化融资结构，2025年上半年成功发行5亿元短期融资券，10月成功发行2025年第一期科技创新债券5亿元；2026年上半年公司有息负债规模较年初有所降低，强化资金管控，财务费用较同期下降1289万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","600812"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665036663","title":"每周股票复盘：华北制药（600812）为子公司担保1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665036663","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665036663?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:39","pubTimestamp":1788637150,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，华北制药报收于4.69元，较上周的4.93元下跌4.87%。本周，华北制药8月31日盘中最高价报4.91元。华北制药当前最新总市值80.47亿元，在化学制药板块市值排名62/149，在两市A股市值排名2191/5214。截至公告日，公司及控股子公司对外担保总额为81,274万元，占最近一期经审计净资产的14.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0239","BK0028","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810518","title":"华北制药（600812）披露为下属子公司提供担保公告，9月2日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810518?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:44","pubTimestamp":1788360255,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，华北制药报收于4.79元，较前一交易日下跌1.64%，最新总市值为82.18亿元。近日，华北制药股份有限公司发布《关于为下属子公司提供担保的公告》。本次担保在公司2025年年度股东会审议通过的担保额度内，无需另行审议。截至公告日，公司及控股子公司对外担保总额为81,274万元，占最近一期经审计净资产的14.74%。存在逾期担保金额9,000万元，系对石家庄焦化集团有限责任公司的担保，目前该债务已被转让，执行程序中止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600812","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663304051","title":"股市必读：华北制药新发布《关于下属公司获得《药品补充申请批准通知书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663304051","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663304051?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:36","pubTimestamp":1788129372,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华北制药报收于4.93元，下跌0.4%，换手率0.78%，成交量13.31万手，成交额6533.15万元。当日关注点交易信息汇总：8月28日主力资金净流出735.11万元，占总成交额11.25%。公司公告汇总：全资子公司深圳华药南方制药获注射用赖氨匹林两个规格《药品补充申请批准通知书》，0.9g规格通过仿制药一致性评价，1.8g规格获批并核发药品批准文号。该产品累计研发投入311.42万元，后续可安排生产和上市销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600812","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048896","title":"每周股票复盘：华北制药（600812）注射用赖氨匹林通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048896","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048896?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:56","pubTimestamp":1788036969,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华北制药报收于4.93元，较上周的4.91元上涨0.41%。本周，华北制药8月27日盘中最高价报4.96元。8月24日盘中最低价报4.56元。华北制药当前最新总市值84.59亿元，在化学制药板块市值排名61/149，在两市A股市值排名2093/5211。本周关注点来自公司公告汇总：注射用赖氨匹林0.9g规格通过仿制药质量和疗效一致性评价，1.8g规格获批并核发药品批准文号。该产品累计研发投入311.42万元，后续可安排生产和上市销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600812","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707587","title":"华北制药最新公告：子公司注射用赖氨匹林通过一致性评价并新增规格","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707587","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662707587?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:49","pubTimestamp":1787824175,"startTime":"0","endTime":"0","summary":"华北制药(600812.SH)公告称，公司全资子公司深圳华药南方制药有限公司收到国家药监局核准签发的注射用赖氨匹林(0.9g、1.8g)《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价，并新增1.8g规格。该药品用于不适用于口服给药的发热及轻、中度疼痛治疗。2025年该产品销售收入1173万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700041841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600812","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661111282","title":"每周股票复盘：华北制药（600812）Q2净利降57.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661111282","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661111282?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:04","pubTimestamp":1787421855,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，华北制药报收于4.91元，较上周的5.04元下跌2.58%。本周，华北制药8月18日盘中最高价报5.22元。股本股东变化股东户数变动截至2026年6月30日，华北制药股东户数为8.86万户，较3月31日减少3223户，减幅3.51%。业绩披露要点财务报告华北制药2026年中报显示，上半年主营收入42.2亿元，同比下降20.01%；归母净利润6384.59万元，同比下降48.3%；扣非净利润5857.59万元，同比下降51.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0239","BK0191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791576217742,"stockEarnings":[{"period":"1week","weight":0.2108},{"period":"1month","weight":0.2562},{"period":"3month","weight":0.308},{"period":"6month","weight":0.0932},{"period":"1year","weight":0.0232},{"period":"ytd","weight":0.0992}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华北制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88579人(较上一季度减少3.51%)","perCapita":"19369股","listingDate":"1994-01-14","address":"河北省石家庄市长安区和平东路388号","registeredCapital":"171573万元","survey":" 华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是化学药、生物药、维生素及健康消费品、农兽药。","listedPrice":4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华北制药,600812,华北制药股票,华北制药股票老虎,华北制药股票老虎国际,华北制药行情,华北制药股票行情,华北制药股价,华北制药股市,华北制药股票价格,华北制药股票交易,华北制药股票购买,华北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}